All In Biotech

Drug Trial Radar · NCT01714973

Study of ST266 Versus Saline in Treating Skin Irritation From Radiation

Phase I Randomized, Blinded Safety and Efficacy Trial of Amnion-derived Cellular Cytokine Solution (ACCS) Versus Saline Sprayed on the Breast of Women Undergoing Radiation Therapy for Breast Cancer After Surgical Removal of the Tumor

Last checked: Nov 19, 2026Latest source record: May 13, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

20

Actual

Start

Oct 2012

Primary completion

Jul 2015

Study completion Oct 2015

Sponsor

Sponsor type
Industry
First posted
Oct 26, 2012

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
Female only, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The objective of this study is to evaluate the safety and efficacy of ST266 in treating radiation burns of the skin in patients undergoing treatments for breast cancer and to compare ST266 treated burns with those treated with saline placebo controls.

Conditions

  • Radiation-induced Dermatitis

Interventions

  • ST266Biological

    Patients will receive ST266 spray, to half the breast and saline to the other half (blinded) after each of ten consecutive radiation therapy treatments. ST266 and saline will be sprayed onto the breast to deliver 0.01 ml/cm2.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Adverse Events (AEs) and Significant Adverse Events (SAEs)Time frame: Start of therapy through six week follow-up visit

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Allegheny General Hospital

    Pittsburgh, Pennsylvania

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.